BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18789702)

  • 21. Design, synthesis and evaluation of novel uracil amino acid conjugates for the inhibition of Trypanosoma cruzi dUTPase.
    Mc Carthy OK; Schipani A; Buendía AM; Ruiz-Perez LM; Kaiser M; Brun R; Pacanowska DG; Gilbert IH
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3809-12. PubMed ID: 16677813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the farnesyl pyrophosphate synthase of Trypanosoma cruzi by homology modeling and molecular dynamics.
    Sigman L; Sánchez VM; Turjanski AG
    J Mol Graph Model; 2006 Nov; 25(3):345-52. PubMed ID: 16540358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
    Alvarez G; Aguirre-López B; Varela J; Cabrera M; Merlino A; López GV; Lavaggi ML; Porcal W; Di Maio R; González M; Cerecetto H; Cabrera N; Pérez-Montfort R; de Gómez-Puyou MT; Gómez-Puyou A
    Eur J Med Chem; 2010 Dec; 45(12):5767-72. PubMed ID: 20889239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives.
    Kim JH; Ryu HW; Shim JH; Park KH; Withers SG
    Chembiochem; 2009 Oct; 10(15):2475-9. PubMed ID: 19780074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates.
    Hudock MP; Sanz-Rodríguez CE; Song Y; Chan JM; Zhang Y; Odeh S; Kosztowski T; Leon-Rossell A; Concepción JL; Yardley V; Croft SL; Urbina JA; Oldfield E
    J Med Chem; 2006 Jan; 49(1):215-23. PubMed ID: 16392806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase.
    Ismail SA; Park HW
    Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1508-13. PubMed ID: 16239728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase: structure, catalytic mechanism and targeted inhibitor design.
    Souza DH; Garratt RC; Araújo AP; Guimarães BG; Jesus WD; Michels PA; Hannaert V; Oliva G
    FEBS Lett; 1998 Mar; 424(3):131-5. PubMed ID: 9580189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
    Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
    Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inactivation of triosephosphate isomerase from Trypanosoma cruzi by brevifolin carboxylate derivatives isolated from Geranium bellum Rose.
    Gayosso-De-Lucio J; Torres-Valencia M; Rojo-Domínguez A; Nájera-Peña H; Aguirre-López B; Salas-Pacheco J; Avitia-Domínguez C; Téllez-Valencia A
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5936-9. PubMed ID: 19733070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro".
    Silva CF; Batista MM; Mota RA; de Souza EM; Stephens CE; Som P; Boykin DW; Soeiro Mde N
    Biochem Pharmacol; 2007 Jun; 73(12):1939-46. PubMed ID: 17462605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of methods in cheminformatics and biocalorimetry for the design of trypanosomatid enzyme inhibitors.
    Prokopczyk IM; Ribeiro JF; Sartori GR; Sesti-Costa R; Silva JS; Freitas RF; Leitão A; Montanari CA
    Future Med Chem; 2014 Jan; 6(1):17-33. PubMed ID: 24358945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
    Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
    Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The catalytic mechanism of glyceraldehyde 3-phosphate dehydrogenase from Trypanosoma cruzi elucidated via the QM/MM approach.
    Reis M; Alves CN; Lameira J; Tuñón I; Martí S; Moliner V
    Phys Chem Chem Phys; 2013 Mar; 15(11):3772-85. PubMed ID: 23389436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design.
    Bressi JC; Verlinde CL; Aronov AM; Shaw ML; Shin SS; Nguyen LN; Suresh S; Buckner FS; Van Voorhis WC; Kuntz ID; Hol WG; Gelb MH
    J Med Chem; 2001 Jun; 44(13):2080-93. PubMed ID: 11405646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does inhibition of Trypanosoma cruzi key enzymes affect parasite life cycle and geographic distribution?
    Salvati L; Bolognesi M; Ascenzi P
    IUBMB Life; 2002 Jan; 53(1):45-7. PubMed ID: 12018407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening.
    Neres J; Brewer ML; Ratier L; Botti H; Buschiazzo A; Edwards PN; Mortenson PN; Charlton MH; Alzari PM; Frasch AC; Bryce RA; Douglas KT
    Bioorg Med Chem Lett; 2009 Feb; 19(3):589-96. PubMed ID: 19144516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Trypanosoma cruzi effects of cyclosporin A derivatives: possible role of a P-glycoprotein and parasite cyclophilins.
    Búa J; Fichera LE; Fuchs AG; Potenza M; Dubin M; Wenger RO; Moretti G; Scabone CM; Ruiz AM
    Parasitology; 2008 Feb; 135(2):217-28. PubMed ID: 17922928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Divalent metal requirements for catalysis and stability of the RNA triphosphatase from Trypanosoma cruzi.
    Massayuki Kikuti C; Tersariol IL; Schenkman S
    Mol Biochem Parasitol; 2006 Nov; 150(1):83-95. PubMed ID: 16887207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and biochemical characterization of novel glucokinases from Trypanosoma cruzi and Leishmania spp.
    Cáceres AJ; Quiñones W; Gualdrón M; Cordeiro A; Avilán L; Michels PA; Concepción JL
    Mol Biochem Parasitol; 2007 Dec; 156(2):235-45. PubMed ID: 17904661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitors of Trypanosoma cruzi trypanothione reductase revealed by virtual screening and parallel synthesis.
    Meiering S; Inhoff O; Mies J; Vincek A; Garcia G; Kramer B; Dormeyer M; Krauth-Siegel RL
    J Med Chem; 2005 Jul; 48(15):4793-802. PubMed ID: 16033259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.